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ABSTRACT Oligomycin-resistant clones were isolated from Chinese hamster ovary cells by
treatment of cells with ethidium bromide, followed by mutagenesis with ethylmethane sulfo-
nate and selection in oligomycin . One clone (Oli' 8.1) was chosen for further study. Olir 8.1
cells grow with a doubling time similar to that of wild-type cells, whether grown in the
presence or absence of drug (doubling time of 13-14 h) . In plating efficiency experiments, Olir
8.1 cells are -100-fold more resistant to oligomycin than are wild-type cells. There is approxi-
mately a 32-fold increase in the resistance to inhibition by oligomycin of the mitochondrial
ATPase from Oli' 8.1 cells. The electron transport chain is functional in Olir 8.1 cells. Oligomycin
resistance is stable in the absence of selective pressure. There is little or no cross-resistance of
Olir 8.1 cells to venturicidin and dicyclohexylcarbodiimide, other inhibitors of the mitochondrial
ATPase, or to chloramphenicol, an inhibitor of mitochondrial protein synthesis. Oligomycin
resistance is dominant in hybrids between Olir 8.1 cells and wild-type cells. Fusions of
enucleated Oli' 8.1 cells with sensitive cells and characterization of the resulting "cybrid"
clones indicates that oligomycin resistance in Olir 8.1 cells is cytoplasmically inherited.
Mitochondria are formed by the close cooperation of the
nuclear and mitochondrial genetic systems. Several compo-
nents of the mitochondrial oxidative phosphorylation systems
(e.g., the ATPase, cytochrome c oxidase, and coenzyme QHZ-
cytochrome c reductase) require the synthesis and assembly of
gene products coded by both the nuclear and mitochondrial
genomes. In lower eukaryotes, the isolation and characteriza-
tion of mutants in both these systems has contributed to our
understanding of the synthesis and assembly of these gene
products and has permitted mapping the genes for several of
the products (for reviews, see references 4, 38, 49). These
mutants have also been used to study the transmission, recom-
bination, and segregation of genes coded by the mitochondrial
DNA (mtDNA) (for reviews, see references 3, 19).
Mutants with alterations in the ATPase have been isolated
and extensively characterized in Saccharomyces cerevisiae and
Neurospora crassa. These include mutants that are resistant to
inhibitorsof the ATPase, such as oligomycin (2, 28, 33, 41-43,
47), and mutants that have lost oligomycin-sensitive ATPase
activity (10, 17, 48). An analysis of these mutants has estab-
lished conclusively that subunit 9 of the ATPase (also known
as the dicyclohexylcarbodiimide [DCCD]-binding protein) is
a product of a mitochondrial gene in S. cerevisiae (42) and a
product of a nuclear gene in N. crassa (41). These studies
confirm earlier work on the biogenesis of the ATPase in these
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organisms (23, 49, 50). There are conflicting reports on the site
of biosynthesis of the DCCD-binding protein in animal cells
(1, 12, 13, 25).
Studies on the biogenesis and genetics of the mammalian
mitochondria have been limited by the lack ofsuitable mutants.
Recently, however, mammalian mutants with alterations in
mitochondrial functions have been isolated and characterized.
Cytoplasmic inheritance can be demonstrated in cells in culture
by transferring the resistant phenotype to sensitive recipient
cells by fusion with enucleated resistant cells (8, 51). Cytoplas-
mic (most likely mitochondrial) mutations that have been
isolated include mutants with resistanceto chloramphenicol (8,
34, 51), antimycin (20), rutamycin (29), erythromycin (16), and
oligomycin (5, 22) and mutants with defects in mitochondrial
protein synthesis (53). Nuclear mutations affecting mitochon-
drial functions have also been isolated (6, 7, 11, 14, 15, 27, 35,
44,45).
In this paper we describe the isolation of Chinese hamster
ovary (CHO) cells that are resistant to oligomycin. Genetic and
biochemical characterization of one such mutant (Oli' 8.1)
indicates that there is an increased resistance of the mitochon-
drial ATPase to oligomycin and that oligomycin resistance is
cytoplasmically inherited. Many of the properties of this mu-
tant differ from the oligomycin-resistant Chinese hamster and
mouse cells that have been isolated in other laboratories (22,
72326, 27, 29). A preliminary account of this work has been
published (5).
MATERIALS AND METHODS
Cells
Wild-type CHOPro- cells (CHO Toronto) wereobtained from Dr. R. Draper,
University of California, San Diego, California. CHO Pro Tg' Oua' Abr' cells
were obtainnd from D. Chin, University of California, San Diego, California,
and are resistant to thioguanine (5 pg/ml), ouabain (2 mM), and abrin (10-" M).
Cell Culture
Cells were routinely grown as monolayers in plastic tissue-culture dishes
(Falcon Labware, Div. Becton, Dickinson &Co., Oxnard,Calif, or Lux Scientific
Corp., Newbury Park, Calif.) or plastic roller bottles (Coming Glass Works,
Science Products Div., Corning, N. Y.) in Dulbecco's modified Eagle's medium
(DMEM; Irvine Scientific, Irvine, Calif.) containing 1 mg/ml glucose, 0.11 mg/
ml sodium pyruvate, and supplemented with nonessential amino acids (Grand
Island Biological Co., Grand Island, N. Y.), 10% fetal calf serum (Irvine Scien-
tific), and antibiotics(growth medium). Cells were grownat 37°C in a humidified
atmosphere of 90% air: l0% CO. In one set of experiments, DMEM without
glucose (GIBCO was supplemented with galactose (I mg/ml), nonessential
amino acids, 10% fetal calfserum, and antibiotics. In another set ofexperiments,
DMEM without glucose and sodium pyruvate (Irvine Scientific) was supple-
mented with glucose (I mg/ml), nonessential amino acids, 10% fetal calf serum
and antibiotics.
Plating Efficiency
10'-10' cells were plated overnight in complete medium in a 100-mm tissue
culture dish.Thefollowing day the mediumwas replaced withmedium containing
various concentrations ofantibiotics or inhibitors. 7-10 dlater the cultures were
fixed and stained with 0.5% crystal violet, and clones containing 50 or more cells
were counted.
Growth Curves
l-2 x 10' cells were plated into a 60-mm tissue culture dish containing either
growth medium or growth medium with oligomycin. Cells were harvested from
duplicate plates at daily intervals and counted in a Coulter counter (Coulter
Electronics, Inc., Hialeah, Fla.).
Enucleation
Cells were enucleated by cytochalasin B treatment in Ficoll gradients, using
the method ofWigler and Weinstein (52).
Cell Fusion
Theproduct ofthe fusion ofan enucleated cell (or cytoplast) and a whole cell
will be referred to as a cybrid, whereas the fusion of two nucleated cells will be
referred to as a hybrid.
Hybrids were obtained by plating I x IG' CHO Tg' Oua' Abr' cells and 1 x
10' CHOOli' 8.1 cells in a 60-mm tissue culture dish. 24 h later the medium was
removed and the cells were treated with 44%polyethylene glycol 6000 (PEG) in
DMEM containing 10% dimethyl sulfoxide (DMSO for 30 s as described (36).
After recovery overnight, the cells were trypsinized and replated into DMEM.
The following day the medium was replaced with selective medium containing
ouabain (1 mM) plus HMT (hypoxanthine, 10-" M; methotrexate, 5.5 x 10-';
thymidine, 10-" M) or ouabain (1 mM)plus oligomycin (0.001 pg/ml). Clones
were isolated or counted -2 wk later.
To obtain cybrids, we fused cytoplasts (enucleated Oli' 8.1 cells) with CHO
Tg' Oua' Abr' cells in suspension, using 44% PEG in DMEM with DMSO as
described (18). Thecells were plated at densities of I x 10' to 1 x l0' per 100-
mm tissue culture dish, and after 24 hselective medium containing oligomycin
(0.001 ug/ml) plus thioguanine (5 pg/ml) was added. Cybrid clones were picked
or counted 14-20 dlater.
Isolation of Mitochondria and Submitochondrial
Particles
Mitochondria were isolated from cells in late-log phase by differential centrif-
ugation as described (15). Submitochondrial particleswere prepared as described
(37).
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ATPase Assays
ATPase in mitochondria and submitochondrial particles was assayed in the
presence ofan ATP-regenerating system as described (21) except that the pH of
the reaction mixture was 8.0.
Oxygen Consumption of Isolated Mitochondria
Oxygen consumption of isolated mitochondria was assayed at 30'C as de-
scribed (15).
Inhibitors and Antibiotics
Stock solutions of oligomycin, rutamycin, and antimycin were prepared in
95%ethanol and added at various concentrations. The maximum final concen-
tration ofethanol was 1% (vol/vol). This concentration ofethanol had no effect
on cell growth, plating efficiency, or ATPase activity. Stocksolutions ofthe other
drugs (thioguanine, ouabain, and chloramphenicol) were prepared in DMEM.
Protein Determination
Protein determination was by the method of Lowry et al. (32), using bovine
serum albumin as a standard.
Chemicals
The following chemicals were from Sigma Chemical Co., St. Louis, Mo.:
thioguanine, adenosine triphosphate, pyruvate kinase, bovine serum albumin,
and Fiske-Subbarow reducer. The following chemicals were obtained from
Calbiochem-Behring Corp., American Hoechst Corp., La Jolla, Calif: oligomy-
cin, antimycin A, ouabain, abrin toxin, chloramphenicol, and ethidiurn bromide.
Ethylmethane sulfonate was from Eastman Kodak Rochester, N. Y., phospho-
enolpyruvate and cytochalasin Bwere from Aldrich Chemical Co., Inc., Milwau-
kee, Wis. and colcemid was from GIBCO. Venturicidin and PEG were from
BDH Chemicals Ltd. Poole, England. Rutamycin was a generous gin of Eli Lilly
Co., Indianapolis, Ind.
RESULTS
Selection of Oligomycin-resistant CHO Cells
The concentration of oligomycin (and other inhibitors of
mitochondrial function) required to kill cells varies greatly
depending on the cell line and on the energy source of the cell.
For example, when galactose (1 mg/ml) is substituted for the
normal concentration ofglucose in the medium (I mg/ml), less
oligomycin is required to kill wild-type CHO cells (Fig. 1).
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FIGURE 1
￿
Relative plating efficiency of wild-type and mutant cells
in the presence of oligomycin in medium containing glucose or
galactose. Relative plating efficiency is the number of clones ap-
pearing in cultures with oligomycin relative to the number of clones
in cultures without oligomycin, expressed as a percent. Control
cultures received the equivalent amount of ethanol . CHO cells in
DMEM containing 1 mg/ml glucose (") ; CHO cells in DMEM
containing 1 mg/mlgalactose (O); Oli' 8.1 cells in DMEM containing
1 mg/ml glucose ("); Oli' 8.1 cells in DMEM containing 1 mg/ml
galactose (A) . Oli' 8.1 cells were grown for over 100 generations in
the absence of oligomycin, and their plating efficiency was retested
in DMEM containing 1 mg/ml glucose (O).Similar effects ofthe energy source on the sensitivity of mouse
cells (22, 35) and Chinese hamster V79 cells (54) to mitochon-
drial inhibitors have been reported.
The oligomycin-resistant CHO cells described in this paper
were selected in DMEM containing 1 mg/ml glucose. CHO
cells were plated at a density of 2 x 10' cells per 100-mm dish
and allowed to attach overnight. The cells were then treated
with ethidium bromide (2.5 1,M) for 24 h in growth medium
and subsequently mutagenized with ethylmethane sulfonate
for 24 h. The mutagen was removed and the cells were allowed
to recover in complete medium for 3 d. Oligomycin (0.001 or
0.005 pg/ml) was then added to the cultures and the medium
was changed every 2 d. After the addition of oligomycin, the
cells continued to grow for - 1 wk, whereupon the majority of
the cells stopped dividing and detached from the surface ofthe
dish. Oligomycin-resistant clones appeared after 2-3 wk, with
most of the dishes containing at least one clone. Clones were
isolated and then subcloned. All of the mutants showed a
modal chromosome number (2n = 20-22) similar to that of the
parental line. One subclone (Oli' 8.1) was chosen for further
study.
Growth Characteristics, Plating Efficiency, and
Stability of Olir 8.1 Cells
The growth characteristics ofthe mutant Oli' 8.1 cells, in the
presence and absence of oligomycin, were compared to that of
the wild-type CHO cells. As shown in Fig. 2, the growth of
CHO cells is inhibited by oligomycin (0.001 pg/ml), whereas
the growth of Oli' 8.1 cells is not. Mutant Oli' 8.1 cells grow
with a doubling time similar to that of wild-type CHO cells,
both in the presence and absence of oligomycin (doubling time
of 13-14 h).
]J r-
id'
w
m
z
w U
IOS
104
0
FIGURE 2 Growth curves of wild-type and oligomycin-resistant
cells in the presence and absence of oligomycin. Wild-type CHO
cells in growth medium without oligomycin (") and in medium
containing 0.001 14g/ml oligomycin (O). Oli` 8.1 cells in medium
without oligomycin (A) and in medium containing 0.001 Fig/ml
oligomycin (A).
The dose-response curves of mutant and wild-type cells to
oligomycin, in medium containing glucose or galactose as the
energy source, are shown in Fig. l. Mutant Oli' 8.1 cells are
- 100-fold more resistant to oligomycinthan are wild-type cells
(asjudged by the concentration ofoligomycin required for 50%
inhibition). Lower concentrations of oligomycin are required
to kill both wild-type and mutant cells when galactose is
substituted for glucose in the medium (Fig. 1). The dose-
response curves of mutant and wild-type cells to oligomycin
are similar in medium with or without sodium pyruvate.
To determine the stability of the resistant phenotype, Oli'
8.1 cells were grown for over 100 generations in the absence of
selective pressure, and the resistance of the cells was retested.
As shown in Fig. 1, oligomycin resistance in Oli' 8.1 cells is
stable in the absence of drug.
Mutant Olir 8.1 Cells Are Not Cross-resistant to
Other Inhibitors of Mitochondrial Function
To determine the specificity of the resistance to oligomycin,
Oli' 8.1 cells were tested for cross-resistance to other inhibitors
ofthe ATPase and of mitochondrial function. Oli' 8.1 cells are
cross-resistant to the closely related drug, rutamycin (oligo-
mycin D). However, Oli' 8.1 cells are not cross-resistant to
N,N'-DCCD, which (like oligomycin) inhibits the mitochon-
drial ATPase by binding to subunit 9 of the enzyme (9, 39, 40,
46), or to venturicidin, which inhibits the mitochondrial ATP-
ase at a site different from oligomycin (31). Oli' 8.1 Cells are
not resistant to ouabain, an inhibitor of the Na',K+-dependent
ATPase of the plasma membrane. Similarly, Oli' 8.1 cells are
not resistant to chloramphenicol, an inhibitor ofmitochondrial
protein synthesis, at 50 tLg/ml. The mutant cells are slightly
more resistant to antimycin (approximately two-to-fivefold),
which inhibits the transfer of electrons between cytochrome b
and c,. Oli' 8.1 cells are also not cross-resistant to colchicine.
This drug was tested because CHO cells selected for resistance
to colchicine display pleiotrophic cross-resistance to a wide
range of drugs as a result of a modification of the plasma
membrane of these cells (24).
Mitochondrial ATPase from Mutant Cells Is
Resistant to Oligomycin
The ability of Oli' 8.1 cells to grow in the presence of
oligomycin could result from several possible alterations in the
cell including a change in the permeability of the plasma
membrane or the mitochondrial membrane or to an increased
resistance of the mitochondrial ATPase to inhibition by oli-
gomycin. To examine these possibilities, we isolated mitochon-
dria and submitochondrial particles from mutant and wild-
type cells and determined ATPase activities as a function of
the oligomycin concentration. Wild-type and mutant mito-
chondria had comparable total ATPase activities. However,
the ATPase activities of mitochondria (Fig. 3) and of submi-
tochondrial particles isolated from Oli' 8.1 cells were more
resistant to oligomycin than was the ATPase activity of CHO
cells. 50% inhibition of ATPase activity was obtained with 0.25
flg of oligomycin per milligram of mitochondria/ protein from
wild-type cells and 8 hg of oligomycin per milligram of mito-
chondrial protein from Olir 8.1 cells, indicating that the ATPase
activity from mutant mitochondria is -32-fold more resistant
to oligomycin. Identical inhibition curves were obtained for
ATPase activity, using mitochondria of Oh' 8.1 cellsgrown for
over 100 generations in the absence of oligomycin. These
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FIGURE 3 Inhibition of the ATPase activity of mitochondria by
oligomycin. ATPase activity of mitochondria from wild-type CHO
cells (") and from Oli' 8.1 cells (A). Thepoints represent theaverage
of the ATPase assays from four experiments. Total ATPase activities
averaged 0.23 tLmol/min per mg for CHO cells and 0.22 trmol/min
per mg for Oli' 8.1 cells.
results indicate that resistance to oligomycin in mutant Oli' 8.1
cells results from an increased resistance of the mitochondria)
ATPase to oligomycin. There is no evidence for a change in
thepermeability oftheplasma membrane or the mitochondria)
membrane to oligomycin.
The Electron Transport Chain Is Functional in
01i' 8.1 Cells
Because ATP synthesis is coupled to electron transfer, we
examined the electron transport chainin Oli' 8.1 cells. Oxygen
consumption by isolated mitochondria from wild-type andOli'
8.1 cells was compared by use of varioussubstrates and inhib-
itors of the electron transport chain. The addition of pyruvate
plus malate stimulated oxygen consumption in both mutant
and wild-type mitochondria. This oxygen consumption was
almost totally inhibited by rotenone or antimycin. Similarly,
the addition of succinate of a-glycerol phosphate stimulated
oxygen consumption in both mutant and wild-type mitochon-
dria. The succinate-dependent oxygen consumption was com-
pletely blocked by malonate and the a-glycerol phosphate-
dependent oxygen consumption was totally blocked by anti-
mycin. These results indicate that the electron transport chain
is functional in the Oli' 8.1 cells.
Oligomycin Resistance Is Dominant in Hybrids
We next examined whether oligomycin resistance behaves
dominantly or recessively in somatic cell hybrids. Hybrids were
made between Oli' 8.1 cells and CHO Tg' Oua' Abr' cells by
selection in medium containing hypoxanthine, methotrexate,
thymidine, and ouabain to avoid selective pressure on the
oligomycin-resistant marker. Hybrid clones were isolated,
grown up, and tested for plating efficiency. As shown in Fig.
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4, the oligomycin resistance of the hybrids is similar to that of
the mutant cells indicating that the mutation is dominant.
Similar results were obtained when hybrids were selected di-
rectly in oligomycin plus ouabain. The hybrid nature of the
clones was confirmed by karyotype analysis, which indicated
that the clones had a near tetraploid modal chromosome
number (Table I), and by plating efficiency experiments, which
indicated that the clones were thioguanine sensitive, ouabain
resistant, and abrin sensitive (Table I).
Cytoplasmic Transfer of Oligomycin Resistance
Experiments were next done to investigate the inheritance of
oligomycin resistance. Oli' 8.1 cells were enucleated and the
resulting cytoplasts were fused with oligomycin-sensitive CHO
Tg' Oua' Abr' cells. The fusion mixturewas placed in medium
containing oligomycin and thioguanine to select against nu-
cleated Oli' 8.1 cells, unfused CHO Tg' Oua' Abr' cells, and
any hybrids resulting from the fusion of nucleated Oli' 8.1 and
CHO Tg' Oua' Abr' cells. As shown in Table II, thioguanine-
and oligomycin-resistant colonies appeared in these plates at a
high frequency relative to the control plates, indicating that
resistance to oligomycin can be transferred by fusion of enu-
cleated Oli' 8.1 cells with sensitive cells. No colonies appeared
in the control plates containing only Oli' 8.1 cells. A significant
number ofcolonies did appear in the control plates containing
CHO Tg'Oua' Abr' cellsaloneor fusion mixtures of nucleated
Oli' 8.1 cells andCHO Tg'Oua' Abr' cells butat a much lower
frequency than that found by enucleated Oli' 8.1 cells with
CHO Tg' Oua' Abr' cells.
Properties of Cybrids
Cybrids formed by the fusion of CHO Tg' Oua' Abr' cells
and enucleated Oli' 8.1 cells should have the following prop-
erties if oligomycin resistance is cytoplasmically inherited: (a)
oligomycin resistance similar to that of mutant Oli' 8.1 cells;
(b) chromosome complement similar that of to CHO Tg' Oua'
Abr' cells; and (c) abrin, ouabain, and thioguanine resistances
similar to those of CHO Tg' Oua' Abr' cells. To examine this,
we isolated several presumptive cybrid clones andstudiedtheir
properties. As shown in Fig. 5, the oligomycin resistance of
these clones was similar to that of the mutant Oli' 8.1 cells
when tested in plating efficiency experiments. The clones also
had the nuclear markers (ouabain, abrin, and thioguanine
resistance) and the chromosome complement (modal chromo-
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FIGURE 4 Relative plating efficiency of wild-type, mutant, and
hybrid cells. Wild-type CHO Tg' Oua' Abr' cells ("); Oli' 8.1 cells
(") ; and hybrids formed between CHO Tg, Oua' Abr' cells and Oli'
8.1 cells (O, 0, O.DISCUSSION
TABLE I
Properties of Parental Lines, Hybrids, and Cybrids
` Sensitivity (S)to oligomycin is defined as theinability of cells to grow in the
presence of 0.001 lug of drug per ml of medium. Resistant cells (R) are
unaffected by this concentration of oligomycin.
fSensitivity (S) to thioguanine is defined as the inability of cells to grow in
the presence of 5 tLg of drug per ml of medium. Resistant cells (R) are
unaffected by this concentration of thioguanine.
§ Sensitivity (S) to ouabain is defined as the inability of cells to grow in the
presence of 1 mM of drug. Resistant cells (R) are unaffected by this
concentration of ouabain.
~~ Sensitivity (S) to abrin toxin is defined as the inabilityof cells to grow in the
presence of 10-' M drug. Resistant cells (R) are unaffected by this concen-
tration of abrin toxin .
TABLE II
Cytoplasmic Transfer of Oligomycin Resistance
Average num-
ber of colonies
Ratio of
￿
per 106 sensi
Cells plated
￿
parents
￿
tive cells
some number 20-24) of the oligomycin-sensitive CHO Tg'
Oua' Abr' parent (Table I). Thus, oligomycin resistance in Oli'
8.1 cells appears to be cytoplasmically inherited.
This paperdescribes a CHO cell line (Oli' 8.1) that is resistant
to oligomycin, an inhibitor of the mitochondria) ATPase. The
general properties of this mutant are: (a) there is an -I00-fold
increase in the resistance of whole cells to oligomycin as
determined by plating efficiency experiments, (b) oligomycin
resistance is stable after many cell divisions in the absence of
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FIGURE 5 Relative plating efficiency of wild-type, mutant, and
cybrid cells. Wild-type CHO Tg' Oua' Abr' cells (") ; Oli' 8.1 cells
(A); and cybrids made between enucleated Oli' 8.1 cells and CHO
Tg' Oud Abr' cells (O,L, O, O) .
drug, (c)the resistance is relatively specific for oligomycin and
rutamycin with little or no cross-resistance to other inhibitors
of the mitochondrial ATPase (such as DCCD or venturicidin)
or an inhibitor of mitochondrial protein synthesis (chloram-
phenicol), (d) there is an -32-fold increase in the resistance of
the mitochondriat ATPase to inhibition by oligomycin with
little change in the total ATPase activity, (e) the electron
transport chain is functional, (/) oligomycin resistance is dom-
inant in hybrids with wild-type cells, (g) oligomycin resistance
is cytoplasmically inherited.
The concentration of oligomycin (and other inhibitors of
mitochondrial function) required to kill cells depends on the
cell line' and on the energy source of the cell. Cells in culture
derive energy from both glycolysis and from oxidative phos-
phorylation. When cellsareexposedto an inhibitorofoxidative
phosphorylation, such as oligomycin, energy must be derived
exclusively from glycolysis. Because the rate of glycolysis is
slower when galactose is used as a carbon source than when
glucose is used, cells are more sensitive to these drugs in
medium containing galactose. However, the relative resistance
of wild-type and mutant cells to inhibition by oligomycin is
expressedindependently of the energy source of thecell, unless
the mutation alters the rate of glycolysis or oxidative phospho-
rylation.
The reduced sensitivity of the mitochondriat ATPase to
oligomycin indicatesthat aconstituent of the ATPase complex
has been modified in the mutant cells. It is possible that a
specific binding site for oligomycin has been altered by the
mutation. Experiments are in progress to determine the molec-
ular nature of the alteration of the ATPase in mutant Oli' 8.1
cells.
The oligomycin-resistant mutant described here was ob-
tained after treatment of CHO cells with ethidium bromide,
followed by mutagenesis with ethylmethane sulfonate in an
effort to reduce the number of mitochondria) genomes per cell
before mutagenesis. Various attempts by others to increase the
frequency of isolation of mitochondria) mutants have been
described (16, 26, 29. 43, 53). However, it has not yet been
demonstrated conclusively that any of these treatments en-
hance the frequency of obtainingmitochondria)DNA mutants,
and more controlled experiments will have to be done to
evaluate the effect of these agents.
' We have observed that different Chinese hamster cell lines vary
greatly in their sensitivity to oligomycin.
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Strains
Model
chromo-
some
number
Oligo-
mycin*
Drug resistance
Thio-
gua- Oua-
nine* bain§ Abrinjj
Parental lines
Olir 8.1 22 R S S S
CHOTg'Oua' Abr' 21 S R R R
Hybrids
(Oli'8.1 X CHO
Tg' Oua' Abr')
H101 40 R S R S
H109 42 R S R S
H111 38 R S R S
H115 41 R S R S
Cybrids
(en Oli' 8.1 X
CHO Tg'Oua' Abr')
Cy2 20 R R R R
Cy3 20 R R R R
Cy4 24 R R R R
Cy5 23 R R R R
Cy6 21 R R R R
Cy12 22 R R R R
Cu13 22 R R R R
Cyl4 21 R R R R
en Oli' 8.1 X CHO Tg'Oua' Abr' 1:1 1,260
5:1 2,970
Oli' 8.1 X CHO Tg' Oua' Abri 1:1 22
5:1 31
Oli' 8.1 - 0
CHO Tg' Oua' Abr' - 46Several otherlaboratories have recently isolated oligomycin-
resistant mouse and hamster cell lines with quite different
properties than the oligomycin-resistant Chinese hamster cell
line described here. For example, the oligomycin-resistant
CHO cells isolated by Lagarde and Siminovitch (27) have a
recessive phenotype and are probably the result of a nuclear
mutation(s). These mutants are cross-resistant to a number of
drugs affecting mitochondria) functions, including rutamycin,
peliomycin, ossamycin, venturicidin, efrapeptin, aurovertin,
antimycin, and chloramphenicol. These mutants cannot grow
when galactose (0.5%) is substituted for glucose in the medium.
No direct examination of the ATPase was carried out and the
biochemical basis forthese oligomycin-resistant mutants is not
clear. On the other hand, rutamycin resistance in the mouse
fibroblasts isolated by Lichtor and Getz (29) appears to be
cytoplasmically inherited. The mutant cells have a decreased
level of mitochondria) ATPase activity and are cross-resistant
to oligomycin, peliomycin, ossamycin, efrapeptin and leuci-
nostatin. The mutant cells are also respiration-deficient and
unable to oxidize substrates that generate NADH (30). In this
regard they resemble a group of respiration-deficient Chinese
hamster fibroblasts with defects in complex I of the electron
transport chain (6, 11). The latter mutants, however, are not
oligomycin resistant (G. A. M. Breen, unpublished observa-
tions). Oligomycin-resistant mouse fibroblasts having an in-
creased resistance of the mitochondria) ATPase to inhibition
by oligomycin, DCCD, and venturicidin have been isolated by
Kuhns and Eisenstadt (26). Both stable and unstable mutants
were isolated. However, the localization of the gene(s) confer-
ring oligomycin resistance in their mutants has not been re-
ported. Oligomycin-resistant mouse fibroblasts have also been
isoated by Howell and Sager (22). No direct examination of
the ATPase was carried out. Direct transmission ofoligomycin
resistance by cytoplast fusions could not be detected with their
mutants, although incomplete cotransmission with chloram-
phenicol resistance was observed. Thus, oligomycin resistance
in mammalian cells can be coded by either nuclear or mito-
chondria) genes, with several phenotypes beingexpressed. Ad-
ditional biochemical experiments will be necessaryto associate
each of these mutations with specific altered proteins.
The oligomycin-resistant mutant described here should pro-
vide a tool to explore the role ofthemammalianmitochondria)
DNA in the biosynthesis of the ATPase. In addition, this
cytoplasmic mutant, together with other cytoplasmic mutants
(e.g., chloramphenicol resistant [8, 34, 51, 541, antimycin re-
sistant [201 and erythromycin resistant [161) will allow us to
study recombination andsegregation in mammalianmitochon-
dria.
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